ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
pld89
|
18K |
7.1M |
1 |
28/07/24 |
28/07/24 |
ASX - By Stock
|
18K
|
7.1M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
pld89
|
943 |
417K |
2 |
27/07/24 |
27/07/24 |
ASX - By Stock
|
943
|
417K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
pld89
|
943 |
417K |
6 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
943
|
417K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
pld89
|
384 |
181K |
8 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
384
|
181K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
pld89
|
12K |
3.9M |
2 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
12K
|
3.9M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
pld89
|
12K |
3.9M |
12 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
12K
|
3.9M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
pld89
|
12K |
3.9M |
7 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
12K
|
3.9M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
pld89
|
12K |
3.9M |
7 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
12K
|
3.9M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
pld89
|
12K |
3.9M |
2 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
12K
|
3.9M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
pld89
|
265 |
109K |
11 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
265
|
109K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
pld89
|
265 |
109K |
2 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
265
|
109K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
pld89
|
265 |
109K |
7 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
265
|
109K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
pld89
|
943 |
417K |
7 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
943
|
417K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
share price
|
|
pld89
|
11 |
5.2K |
3 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
11
|
5.2K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Presentation on ASX Gems Conference on 21st June
|
|
pld89
|
199 |
76K |
4 |
25/06/24 |
25/06/24 |
ASX - By Stock
|
199
|
76K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Presentation on ASX Gems Conference on 21st June
|
|
pld89
|
199 |
76K |
1 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
199
|
76K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Presentation on ASX Gems Conference on 21st June
|
|
pld89
|
199 |
76K |
7 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
199
|
76K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
pld89
|
18K |
7.1M |
4 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
18K
|
7.1M
|
4
|
|
ASX - By Stock
|
EIQ |
Re:
Ann: Validation of EIQ AI at Leading Scientific Conference
|
|
pld89
|
10 |
4.9K |
0 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
10
|
4.9K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Presentation on ASX Gems Conference on 21st June
|
|
pld89
|
199 |
76K |
5 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
199
|
76K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
pld89
|
12K |
3.9M |
3 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
12K
|
3.9M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
pld89
|
1.0K |
453K |
26 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
1.0K
|
453K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
pld89
|
225 |
86K |
8 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
225
|
86K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
pld89
|
1.0K |
453K |
3 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
1.0K
|
453K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
pld89
|
1.0K |
453K |
5 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
1.0K
|
453K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
pld89
|
225 |
86K |
4 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
225
|
86K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
pld89
|
225 |
86K |
5 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
225
|
86K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
pld89
|
18K |
7.1M |
8 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
18K
|
7.1M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
June 24 - MSB % of portfolio AND + or - %
|
|
pld89
|
88 |
36K |
3 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
88
|
36K
|
3
|
|
ASX - By Stock
|
EIQ |
Re:
Ann: Validation of EIQ AI at Leading Scientific Conference
|
|
pld89
|
10 |
4.9K |
0 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
10
|
4.9K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
pld89
|
245 |
98K |
6 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
245
|
98K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
pld89
|
245 |
98K |
2 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
245
|
98K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
pld89
|
245 |
98K |
4 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
245
|
98K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
pld89
|
245 |
98K |
7 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
245
|
98K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
pld89
|
245 |
98K |
8 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
245
|
98K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
pld89
|
245 |
98K |
2 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
245
|
98K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
pld89
|
245 |
98K |
3 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
245
|
98K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
pld89
|
245 |
98K |
2 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
245
|
98K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
pld89
|
245 |
98K |
3 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
245
|
98K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
pld89
|
245 |
98K |
5 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
245
|
98K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
pld89
|
245 |
98K |
16 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
245
|
98K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
pld89
|
1.0K |
453K |
9 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
1.0K
|
453K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
pld89
|
18K |
7.1M |
4 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
18K
|
7.1M
|
4
|
|
ASX - By Stock
|
EIQ |
Re:
Ann: Investor Presentation
|
|
pld89
|
7 |
2.9K |
2 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
7
|
2.9K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
pld89
|
6.0K |
3.0M |
5 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
5
|
|
ASX - By Stock
|
EIQ |
Re:
Ann: Echo IQ Commences New Heart Failure Clinical Study Using AI
|
|
pld89
|
3 |
1.1K |
0 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
3
|
1.1K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
pld89
|
204 |
82K |
1 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
204
|
82K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
pld89
|
204 |
82K |
4 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
204
|
82K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
pld89
|
204 |
82K |
9 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
204
|
82K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
pld89
|
1.3K |
431K |
6 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
1.3K
|
431K
|
6
|
|